Xcorporeal Financial Statements
Xcorporeal Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Xcorporeal Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (18.3) | 4.5 | (0.2) |
| Total Net Income ($ mil.) | (17.1) | 5.3 | (0.7) |
| Diluted EPS (Net Income) | (1.20) | 45.82 | (5.79) |
Xcorporeal Stock Quote & Chart
12/01/08 15:44:50 EST •
AMEX •
0.16
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Xcorporeal Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 2.19 | 1.56 |
| Price/Earnings Ratio | -- | 22.29 | 15.82 |
| Price/Book Ratio | 1.34 | 2.28 | 1.52 |
| Price/Cash Flow Ratio | -- | 15.76 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Xcorporeal Financial Ratios
Xcorporeal Competitive Intelligence
| B. Braun Melsungen | Fresenius Medical Care | Gambro AB | |
|---|---|---|---|
| Annual Sales ($ mil.) | 3,809.9 | 6,228.0 | 1,844.4 |
| Employees | 29,842 | 44,526 | 19,143 |
| Market Cap ($ mil.) | -- | -- | -- |
Competitive Landscape
